Doximity, Inc. ( (DOCS) ) has released its Q2 earnings. Here is a breakdown of the information Doximity, Inc. presented to its investors.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Doximity, Inc., a prominent digital platform for U.S. medical professionals, provides tools that enhance productivity and patient care. In its fiscal 2026 second quarter, Doximity reported a 23% increase in total revenues, reaching $168.5 million, alongside a significant rise in operating and free cash flows, both up by 37% year-over-year. The company also noted a substantial growth in AI tool usage, with AI Scribe and DoxGPT users increasing by over 50% from the previous quarter.
Key financial highlights include a net income of $62.1 million, reflecting a margin of 36.8%, and an adjusted EBITDA of $100.8 million, marking a 32% increase year-over-year. The company also achieved a diluted net income per share of $0.31 and a non-GAAP diluted net income per share of $0.45. These figures underscore Doximity’s robust financial health and operational efficiency.
Doximity’s strategic focus on AI-driven tools and services continues to drive its growth, with a record 650,000 prescribers utilizing its workflow tools. The company’s financial outlook for the next quarter anticipates revenues between $180 million and $181 million, and an adjusted EBITDA between $103 million and $104 million, indicating sustained growth momentum.
Looking ahead, Doximity remains optimistic about its fiscal year ending March 31, 2026, projecting revenues between $640 million and $646 million, and adjusted EBITDA between $351 million and $357 million. The company is poised to maintain its leadership in the digital healthcare sector, leveraging its innovative platform to enhance medical professionals’ efficiency and patient care.